Search results
Author(s):
Belén Biscotti Rodil
,
Juan Duarte Torres
,
Irene Martín de Miguel
,
et al
Added:
1 month ago
Author(s):
Armin Arbab-Zadeh
,
Michelle Graham
,
Hector M Garcia-Garcia
,
et al
Added:
4 months ago
Author(s):
Frederick Welt
Added:
3 months ago
Learn about the definition and implications of a shock diagnosis and systems of care and the role of the shock team from Dr Frederick Welt (University of Utah, US).This three-part video lecture series, part of Women As One’s CLIMB® 2025 Skills Training Programme, offers case-based insights into Coronary and Mechanical Support for Cardiogenic Shock, curated by Dr Alison Duncan and Dr Frederick…
View more
Author(s):
Kevin S Tang
,
Shoujit Banerjee
,
George Tang
,
et al
Added:
2 years ago
Evolving Strategies in Pulmonary Embolism: From Risk Stratification to Interventional Therapy
Author(s):
Stavros Konstantinides
,
José M Montero-Cabezas
,
Mario Iannaccone
,
et al
Added:
1 month ago
Video Series
Author(s):
Marianne Brodmann
Added:
11 months ago
LINC 2025 - 12-month amputation and readmission rates from the TRUE-PTX study suggests endovascular revascularisation for peripheral artery disease (PAD) with drug-eluting devices lead to better outcomes than with bare device therapies.Dr Marianne Brodmann (Medical University of Graz, AT) joins us to discuss the TRUE-PTX study evaluating a database of patients in the US with PAD who have recieved…
View more
Author(s):
Francesco Pelliccia
Added:
8 months ago
SCAI 2025 - Insights from antiplatelet therapy after transcatheter aortic valve replacement (TAVR) show patients who received single antiplatelet treatment had significantly lower rates of overall six-month mortality, CV death and non-CV death compared to those treated with double antiplatelet treatment.Dr Francesco Pelliccia (Sapienza University of Rome, Rome, IT) joins us to discuss insights…
View more
Author(s):
Susheel Kodali
Added:
1 year ago
TCT Conference 2024 - Safety and efficacy outcomes of transcatheter tricuspid valve replacement (TTVR) compared to optimal medical therapy for patients with severe tricuspid regurgitation (TR).Dr Susheel Kodali (Columbia University Medical Center, New York, US) joins us onsite at TCT Conference to discuss the findings from the TRISCEND II Trial (NCT04482062; Edwards Lifesciences).TRISCEND II is a…
View more
Author(s):
Stefan Stortecky
Added:
10 months ago
CRT 25 - Outcomes in patients with intermediate-risk pulmonary embolism (PE) with contraindications to thrombolytics show large-bore mechanical thrombectomy is a safe and effective treatment option for this comorbid patient population. In the contraindication cohort, large-bore mechanical thrombectomy was successfully performed with no in-hospital mortality or intracranial haemorrhage.Dr Stefan…
View more
Author(s):
Kevin Cheng
,
Jonathan M Hill
,
Ranil de Silva
Added:
1 year ago